U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213869) titled 'Alpha tACS for Disorders of Consciousness : a Single Case Experimental Design' on Oct. 02.
Brief Summary: BRIEF SUMMARY * (Include a statement of the study hypothesis) Avoid all personal pronouns (Limit: 5000 characters) Disorders of consciousness (DoC) following a severe traumatic brain injury represent a major medical challenge, with very limited therapeutic options and many patients remaining in a minimally conscious state or vegetative/unresponsive wakefulness state for months. To date, only two pharmacological treatments (amantadine and zolpidem) have shown partial benefits. Non-invasive neuromodulation techniques such as trans...